BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8772232)

  • 41. Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator.
    Akol H; Boon E; van Haren F; van der Hoeven J
    Eur J Intern Med; 2002 Sep; 13(6):389. PubMed ID: 12225785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
    Koyama K; Nunomiya S
    J Intensive Care; 2017; 5():63. PubMed ID: 29158900
    [No Abstract]   [Full Text] [Related]  

  • 43. Cases of Generalised Septic Infection Treated with Antistreptococcus Serum.
    Mackie FP
    Br Med J; 1899 Jan; 1(1986):142-3. PubMed ID: 20758271
    [No Abstract]   [Full Text] [Related]  

  • 44. All tangled up: interactions of the fibrinolytic and innate immune systems.
    Whyte CS
    Front Med (Lausanne); 2023; 10():1212201. PubMed ID: 37332750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of plasminogen activator inhibitor-2 in pneumococcal meningitis.
    Teske NC; Engelen-Lee JY; Dyckhoff-Shen S; Pfister HW; Klein M; van de Beek D; Kirschning CK; Koedel U; Brouwer MC
    Acta Neuropathol Commun; 2022 Oct; 10(1):155. PubMed ID: 36309755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci; 2001 Jun; 21(12):4336-47. PubMed ID: 11404419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.
    Haj MA; Robbie LA; Croll A; Adey GD; Bennett B
    Intensive Care Med; 1998 Mar; 24(3):258-61. PubMed ID: 9565810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.
    Hermans PW; Hazelzet JA
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S453-8. PubMed ID: 16237647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of interrelationship of neutrophils, endotheliocytes and mononuclear macrophages in occurrence and course of purulent-septic state. Communication 5. Mechanisms of kinetics of neutrophyl].
    Medvats'kyĭ IeB; Zubkov VI; Dubov AM; Vlaĭkov HH; Steblyna VIe; Kryzhevs'kyĭ VV; Lytvynenko OM
    Klin Khir; 2004 Jul; (7):51-3. PubMed ID: 15495617
    [No Abstract]   [Full Text] [Related]  

  • 50. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
    Mesters RM; Flörke N; Ostermann H; Kienast J
    Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TAFI and PAI-1 levels in human sepsis.
    Zeerleder S; Schroeder V; Hack CE; Kohler HP; Wuillemin WA
    Thromb Res; 2006; 118(2):205-12. PubMed ID: 16009400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
    Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
    Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients.
    Haj MA; Robbie LA; Adey GD; Bennett B
    Thromb Haemost; 1995 Dec; 74(6):1528-32. PubMed ID: 8772232
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.